Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cserepes M, Nelhűbel GA, Meilinger-Dobra M, Herczeg A, Türk D, Hegedűs Z, Svajda L, Rásó E, Ladányi A, Csikó KG, Kenessey I, Szöőr Á, Vereb G, Remenár É, Tóvári J. Cserepes M, et al. Among authors: hegedus z. Cancers (Basel). 2022 May 13;14(10):2407. doi: 10.3390/cancers14102407. Cancers (Basel). 2022. PMID: 35626010 Free PMC article.
Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
Szabó B, Nelhubel GA, Kárpáti A, Kenessey I, Jóri B, Székely C, Peták I, Lotz G, Hegedus Z, Hegedus B, Füle T, Döme B, Tímár J, Tóvári J. Szabó B, et al. Among authors: hegedus z, hegedus b. Oral Oncol. 2011 Jun;47(6):487-96. doi: 10.1016/j.oraloncology.2011.03.020. Epub 2011 Apr 16. Oral Oncol. 2011. PMID: 21498106
EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas.
Nelhűbel GA, Cserepes M, Szabó B, Türk D, Kárpáti A, Kenessey I, Rásó E, Barbai T, Hegedűs Z, László V, Szokol B, Dobos J, Őrfi L, Tóvári J. Nelhűbel GA, et al. Among authors: hegedus z. Pathol Oncol Res. 2021 May 3;27:620256. doi: 10.3389/pore.2021.620256. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257586 Free PMC article.
Synthesis and characterization of new fluorescent boro-β-carboline dyes.
Szepesi Kovács D, Hajdu I, Mészáros G, Wittner L, Meszéna D, Tóth EZ, Hegedűs Z, Ranđelović I, Tóvári J, Szabó T, Szilágyi B, Milen M, Keserű GM, Ábrányi-Balogh P. Szepesi Kovács D, et al. Among authors: hegedus z. RSC Adv. 2021 Apr 1;11(21):12802-12807. doi: 10.1039/d1ra02132j. eCollection 2021 Mar 29. RSC Adv. 2021. PMID: 35423835 Free PMC article.
The effect of conjugation on antitumor activity of vindoline derivatives with octaarginine, a cell-penetrating peptide.
Bánóczi Z, Keglevich A, Szabó I, Ranđelović I, Hegedüs Z, Regenbach FL, Keglevich P, Lengyel Z, Gorka-Kereskényi Á, Dubrovay Z, Háda V, Szigetvári Á, Szántay C Jr, Hazai L, Tóvári J, Hudecz F. Bánóczi Z, et al. Among authors: hegedus z. J Pept Sci. 2018 Oct;24(10):e3118. doi: 10.1002/psc.3118. Epub 2018 Aug 6. J Pept Sci. 2018. PMID: 30084214 Free article.
EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.
Schweiger T, Hegedüs B, Nikolowsky C, Hegedüs Z, Szirtes I, Mair R, Birner P, Döme B, Lang G, Klepetko W, Ankersmit HJ, Hoetzenecker K. Schweiger T, et al. Among authors: hegedus z, hegedus b. Ann Surg Oncol. 2014 Mar;21(3):946-54. doi: 10.1245/s10434-013-3386-7. Epub 2013 Nov 27. Ann Surg Oncol. 2014. PMID: 24281417 Clinical Trial.
Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.
Virág J, Haberler C, Baksa G, Piurkó V, Hegedüs Z, Reiniger L, Bálint K, Chocholous M, Kiss A, Lotz G, Glasz T, Schaff Z, Garami M, Hegedűs B. Virág J, et al. Among authors: hegedus z, hegedus b. Pathol Oncol Res. 2017 Apr;23(2):245-252. doi: 10.1007/s12253-016-0084-3. Epub 2016 Jul 9. Pathol Oncol Res. 2017. PMID: 27395057 Free PMC article.
144 results